Lilly CEO Dave Ricks recently noted that Foundayo is not more effective than the companys injectable Zepbound, he told CNBC, but its more accessible, its easier to fit into your daily routine. In ATTAIN-1 trials, patients on the highest dose lost an average of 12.4% of their body weight over 72 weeks, compared to the 20%-plus weight loss typically seen with injectable tirzepatide
Not all body locations absorb GLP-1 medications equally, and some sites are simply more comfortable than others
Lillys Trulicity is a once-weekly injectable treatment for type 2 diabetes that lowers blood sugar levels and supports weight loss
Santo SS, Sergio N, Giuseppe M, Margherita F, Gea OC, Roberto F, et al
If appropriate, your semaglutide plan is coordinated with transparent pricing and discreet delivery